Coverart for item
The Resource Integrated molecular medicine for neuronal and neoplastic disorders, edited by Gen Sobue [and others]

Integrated molecular medicine for neuronal and neoplastic disorders, edited by Gen Sobue [and others]

Label
Integrated molecular medicine for neuronal and neoplastic disorders
Title
Integrated molecular medicine for neuronal and neoplastic disorders
Statement of responsibility
edited by Gen Sobue [and others]
Contributor
Subject
Genre
Language
eng
Member of
Additional physical form
Also issued on the Internet.
Cataloging source
DNLM/DLC
Illustrations
illustrations
Index
index present
LC call number
RC365
LC item number
.I578 2006
Literary form
non fiction
Nature of contents
bibliography
NLM call number
WL 359
NLM item number
I605 2006
http://library.link/vocab/relatedWorkOrContributorDate
2005
http://library.link/vocab/relatedWorkOrContributorName
  • Sobue, Gen
  • New York Academy of Sciences
  • Nagoya Daigaku
  • International COE Symposium on Elucidation of Pathogenesis and Therapy Development for Neurological and Psychiatric Disorders
Series statement
Annals of the New York Academy of Sciences,
Series volume
v. 1086
http://library.link/vocab/subjectName
  • Nervous system
  • Cancer
  • Neurodegenerative Diseases
  • Neurodegenerative Diseases
  • Molecular Mechanisms of Pharmacological Action
  • Neoplasms
  • Neoplasms
  • Pharmacogenetics
Label
Integrated molecular medicine for neuronal and neoplastic disorders, edited by Gen Sobue [and others]
Instantiates
Publication
Note
"Result of a meeting entitled Third International COE Symposium on Elucidation of Pathogeneis and Therapy Development for Neurological and Psychiatric Disorders ... held in Nagoya, Japan on December 1-2, 2005."--Contents p
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Motor neuron diseases -- Gene expression profiling toward understanding of ALS pathogenesis -- Role of polyunsaturated fatty acids for misfolding protein aggregations: implications for neurodegenerative diseases -- Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG) -- Alzheimer's disease and related neurodegenerative disorders -- LRP in amyloid-Ý production and metabolism -- Neuronal differentiation is accompanied by increased levels of SNAP-25 protein in fetal rat primary cortical neurons: implications in neuronal plasticity and Alzheimer's disease -- Myosin Va mutation in rats is an animal model for the human hereditary neurological disease, Griscelli syndrome type 1 -- Neuroprotective strategy for neurodegenerative diseases -- Brain keratan sulfate and glial scar formation -- Direct and indirect effects of serofendic acid on neuroprotection -- Cytoplasmic lipid droplets: rediscovery of an old structure as a unique platform -- Neuronal polarity and psychiatric disorders -- Molecular mechanisms of axon specification and neuronal disorders -- Disrupted-in-schizophrenia-1 (DISC-1): a key susceptibility factor for major mental illnesses -- Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans -- Investigating gene-to-behavior pathways in psychiatric disorders: the use of a comprehensive behavioral test battery on genetically engineered mice -- Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine -- Novel targets for cancer therapy -- Girdin, a novel actin-binding protein, and its family of proteins possess versatile functions in the Akt and Wnt signaling pathways -- Biosignals modulated by tumor-associated carbohydrate antigens: novel targets for cancer therapy -- FAK signaling in neoplastic disorders: a linkage between inflammation and cancer -- SFK-STAT pathway: an alternative and important way to malignancies -- Pharmacogenetic approach for cancer treatment-tailored medicine in practice -- Involvement of DPPIV/CD26 in epithelial morphology and suppressed invasive ability in ovarian carcinoma cells
Control code
72354013
Dimensions
24 cm
Dimensions
unknown
Extent
xii, 243 pages
Isbn
9781573316552
Isbn Type
(paper : alk. paper)
Lccn
2006032973
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other control number
9781573316552
Other physical details
illustrations
Specific material designation
remote
Label
Integrated molecular medicine for neuronal and neoplastic disorders, edited by Gen Sobue [and others]
Publication
Note
"Result of a meeting entitled Third International COE Symposium on Elucidation of Pathogeneis and Therapy Development for Neurological and Psychiatric Disorders ... held in Nagoya, Japan on December 1-2, 2005."--Contents p
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Motor neuron diseases -- Gene expression profiling toward understanding of ALS pathogenesis -- Role of polyunsaturated fatty acids for misfolding protein aggregations: implications for neurodegenerative diseases -- Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG) -- Alzheimer's disease and related neurodegenerative disorders -- LRP in amyloid-Ý production and metabolism -- Neuronal differentiation is accompanied by increased levels of SNAP-25 protein in fetal rat primary cortical neurons: implications in neuronal plasticity and Alzheimer's disease -- Myosin Va mutation in rats is an animal model for the human hereditary neurological disease, Griscelli syndrome type 1 -- Neuroprotective strategy for neurodegenerative diseases -- Brain keratan sulfate and glial scar formation -- Direct and indirect effects of serofendic acid on neuroprotection -- Cytoplasmic lipid droplets: rediscovery of an old structure as a unique platform -- Neuronal polarity and psychiatric disorders -- Molecular mechanisms of axon specification and neuronal disorders -- Disrupted-in-schizophrenia-1 (DISC-1): a key susceptibility factor for major mental illnesses -- Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans -- Investigating gene-to-behavior pathways in psychiatric disorders: the use of a comprehensive behavioral test battery on genetically engineered mice -- Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine -- Novel targets for cancer therapy -- Girdin, a novel actin-binding protein, and its family of proteins possess versatile functions in the Akt and Wnt signaling pathways -- Biosignals modulated by tumor-associated carbohydrate antigens: novel targets for cancer therapy -- FAK signaling in neoplastic disorders: a linkage between inflammation and cancer -- SFK-STAT pathway: an alternative and important way to malignancies -- Pharmacogenetic approach for cancer treatment-tailored medicine in practice -- Involvement of DPPIV/CD26 in epithelial morphology and suppressed invasive ability in ovarian carcinoma cells
Control code
72354013
Dimensions
24 cm
Dimensions
unknown
Extent
xii, 243 pages
Isbn
9781573316552
Isbn Type
(paper : alk. paper)
Lccn
2006032973
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other control number
9781573316552
Other physical details
illustrations
Specific material designation
remote

Library Locations

    • Thomas Jefferson LibraryBorrow it
      1 University Blvd, St. Louis, MO, 63121, US
      38.710138 -90.311107
Processing Feedback ...